Pharma Archives - Page 80 of 83 - Boston Life Sciences Times

Pharma

Reverie Labs Raises $25 Million Series A Round

Life Sciences Times - February 5, 2021 0

Pharma

MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

Life Sciences Times - February 4, 2021 0

Pharma

AstraZeneca says vaccine 76% effective for 90 days after single dose

Life Sciences Times - February 3, 2021 0

Pharma

Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research Institute

Life Sciences Times - February 2, 2021 0

Pharma

Pfizer-BioNTech to produce 2 billion doses of Covid vaccine in 2021

Life Sciences Times - February 2, 2021 0

Pharma

Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial

Life Sciences Times - February 1, 2021 0

Pharma

Fractyl Announces Publication of Clinical Results from INSPIRE Study Showing Durable Insulin-Free Glycemic Control in Majority of Patients Treated

Life Sciences Times - February 1, 2021 0

Pharma

EU authorizes AstraZeneca/Oxford COVID-19 vaccine

Life Sciences Times - January 30, 2021 0

Pharma

Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand

Life Sciences Times - January 29, 2021 0

Pharma

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Life Sciences Times - January 29, 2021 0

Pharma

Novavax Covid-19 vaccine found 89.3% effective

Life Sciences Times - January 29, 2021 0

Pharma

J&J single-shot Covid-19 vaccine shows 66% efficacy overall

Life Sciences Times - January 29, 2021 0

1...798081...83 Page 80 of 83

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

November 26, 2025

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

November 26, 2025

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

November 26, 2025

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

November 26, 2025

Pharma

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

PharmaEssentia Highlights Publication of Phase 3 SURPASS-ET Trial Results in The Lancet Haematology

Most Read

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

EDITOR PICKS

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

THIS WEEK'S STORIES

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Enveric Biosciences Gains Fourth Notice of Allowance for EVM401 Drug Candidate Series

MindImmune Extends Series A to $30 Million to Advance Alzheimer’s Therapy and Names Isaac Stoner as CEO

POPULAR CATEGORY

ABOUT US

FOLLOW US